...
首页> 外文期刊>Pediatric surgery international >Protocol for enhanced recovery after surgery with 3D laparoscopic excision for choledochal cysts can benefit the recovery process
【24h】

Protocol for enhanced recovery after surgery with 3D laparoscopic excision for choledochal cysts can benefit the recovery process

机译:用于增强恢复的康复后的恢复的协议,用于Choledochal囊肿的3D腹腔镜切除可以使恢复过程有益

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To explore the clinical value of enhanced recovery after surgery (ERAS) with laparoscopic choledochal cyst (CDC) excision in children. Methods A retrospective review was performed on the clinical data from 33 in-patients whose final diagnosis was CDC. We included 18 patients who underwent the traditional treatment for CDC from April 2017 to October 2017 as the control group and 15 patients who underwent the enhanced recovery protocol (ERP) from November 2017 to May 2018 as the ERAS group. All the patients had received three-dimensional (3D) laparoscopic choledochal cyst excision and Roux-en-Y hepaticojejunostomy by the same group of pediatric surgeons. The time of initial water intake, postoperative time to total enteral nutrition (TEN), postoperative hospital stay, total cost in hospital, postoperative complications, and readmission rate within 30 days were analysed. Results The postoperative time of initial water intake, postoperative time to TEN, postoperative hospital stay, and total cost in hospital were (21.5 +/- 2.1) h, (4.3 +/- 0.5) days, (5.3 +/- 0.6) days, and (35,945.49 +/- 6071.46) China Yuan (CNY) in the ERAS group and (44.1 +/- 3.5) h, (7.7 +/- 2) days, (9.1 +/- 2.5) days, and (45,609.08 +/- 11,439.80) CNY in the control group, respectively. These values in the ERAS group were significantly lower than those in the control group (p < 0.05). There was no significant difference between the two groups in terms of postoperative complications. No readmission patient within 30 days was encountered in either of the two groups. Conclusion Enhanced recovery protocols can shorten postoperative hospital stay, relieve perioperative discomfort, lighten the financial burden, and result in substantial improvements.
机译:目的探讨腹腔镜Choledochal囊肿(CDC)切除腹腔镜(ERAS)在手术后恢复的临床价值。方法对来自33例患者的临床资料进行回顾性评论,其最终诊断为CDC。我们包括从2017年4月到2017年4月到2017年10月的CDC传统治疗的18名患者,作为对照组和15名患者从2017年11月到2018年5月作为Eras集团的加强恢复议定书(ERP)。所有患者都接受了同一组儿科外科医生的三维(3D)腹腔镜胆总管囊肿和Roux-Zh-Y Hepaticojejunostomy。分析了初始水摄入量,术后时间肠内营养(十),术后住院住院,医院总成本,术后复杂性和入院率在30天内进行了30天。结果初始水摄入量,术后时间术后时间术后,术后,术后的住院住院和医院总成本(21.5 +/- 2.1)H,(4.3 +/- 0.5)天(5.3 +/- 0.6)天,(35,945.49 +/- 6071.46)中国人民币(CNY)在ERAS集团和(44.1 +/- 3.5)H,(7.7 +/- 2)天,(9.1 +/- 2.5)天,(45,609.08 + / - 11,439.80)分别在对照组中CNY。 Eras组中的这些值显着低于对照组(P <0.05)。两组在术后并发症方面没有显着差异。两组中的任何一个都遇到了30天内的再入院患者。结论增强的恢复协议可以缩短术后住院住院,缓解围手术期不适,减轻金融负担,导致实质性改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号